Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Salles
    Salles
  9. Horwitz
    Horwitz
  10. Perales
    Perales

Groups

  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (44)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (124)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (355)
  2. Haematologica Meeting Reports (4)

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patrones de cambio de los inhibidores de la tirosina cinasa BCR-ABL1 en pacientes con LMC en fase crónica en la práctica clínica rutinaria estudio simplicity
    Meeting Abstract

    Encinas, M. P.; Goldberg, S. L.; Michallet, M.; Hehlmann, R.; Zyczynski, T.; Foreman, A.; Calimlim, B.; Paquette, R.; Simonsson, B.; Gambacorti Passerini, C.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) Vs Imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE Trial
    Meeting Abstract

    Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; Hochhaus, A.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • NEOD001 demuestra respuesta orgánica en pacientes con amiloidosis de cadena ligera y disfunción orgánica persistente, independientemente de la respuesta hematológica previa
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematologic response
    Meeting Abstract

    Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Merlini, G.; Walling, J.; Kinney, G.; Koller, M.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma
    Journal Article

    Younes, A.; Salles, G.; Martinelli, G.; Bociek, R. G.; Barrigon, D. C.; González Barca, E.; Turgut, M.; Gerecitano, J.; Kong, O.; Pisal, C. B.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: Results from an expanded phase I trial
    Journal Article

    Oki, Y.; Kelly, K. R.; Flinn, I.; Patel, M. R.; Gharavi, R.; Ma, A.; Parker, J.; Hafeez, A.; Tuck, D.; Younes, A.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor
    Journal Article

    Vaisitti, T.; Gaudino, F.; Ouk, S.; Moscvin, M.; Vitale, N.; Serra, S.; Arruga, F.; Zakrzewski, J. L.; Liou, H. C.; Allan, J. N.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Impact of baseline bilirubin on survival in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome receiving defibrotide: Post-hoc analysis of expanded-access protocol final data
    Meeting Abstract

    Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Timing of defibrotide initiation post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation: Expanded access program final data
    Meeting Abstract

    Grupp, S.; Richardson, P.; Smith, A.; Kernan, N.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; Tappe, W.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • The dual SYK/JAK inhibitor cerdulatinib demonstrates complete inhibition of SYK and JAK and rapid tumor responses in a phase 2 study in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Farber, C.; Fenske, T.; Khatcheressian, J.; Miller, C.; Munoz, J.; Patel, M.; Smith, S.; Stevens, D.; Pandey, A.; more...
    Haematologica (2017)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: